Quinolone Resistance-Associated Mutations in Mycoplasma genitalium: Not Ready for Prime Time.
作者信息
Manhart Lisa E, Jensen Jørgen S
机构信息
From the Departments of Epidemiology and Global Health and Center for AIDS and STD, University of Washington, Seattle, WA.
Department of Bacteria, parasites and Fungi, Research Unit for Reproductive Microbiology, Statens Serum Institut, Denmark, Copenhagen.
出版信息
Sex Transm Dis. 2020 Mar;47(3):199-201. doi: 10.1097/OLQ.0000000000001132.
Abstract
摘要
相似文献
1
Quinolone Resistance-Associated Mutations in Mycoplasma genitalium: Not Ready for Prime Time.生殖支原体中喹诺酮耐药相关突变：尚不成熟。
Sex Transm Dis. 2020 Mar;47(3):199-201. doi: 10.1097/OLQ.0000000000001132.
2
Clearance of Mycoplasma genitalium Infection With Moxifloxacin in the Presence of Quinolone Resistance-Associated Mutations.存在喹诺酮类耐药相关突变时莫西沙星清除泌尿生殖道支原体感染。
Sex Transm Dis. 2020 Mar;47(3):197-198. doi: 10.1097/OLQ.0000000000001095.
3
Evaluation of the SpeeDx MG (Beta) PCR Assay for Rapid Detection of Mycoplasma genitalium Quinolone Resistance-Associated Mutations.用于快速检测生殖支原体喹诺酮耐药相关突变的SpeeDx MG（β）PCR检测法的评估
J Clin Microbiol. 2020 Sep 22;58(10). doi: 10.1128/JCM.01432-20.
4
Moxifloxacin and Sitafloxacin Treatment Failure in Mycoplasma genitalium Infection: Association with parC Mutation G248T (S83I) and Concurrent gyrA Mutations.莫西沙星和司帕沙星治疗失败支原体生殖器感染：与 parC 突变 G248T（S83I）和并发 gyrA 突变相关。
J Infect Dis. 2020 Mar 2;221(6):1017-1024. doi: 10.1093/infdis/jiz550.
5
Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens.大环内酯类耐药和阿奇霉素治疗失败的支原体生殖器感染队列和阿奇霉素治疗失败对替代抗生素方案的反应。
Clin Infect Dis. 2015 Apr 15;60(8):1228-36. doi: 10.1093/cid/ciu1162. Epub 2014 Dec 23.
6
Macrolide and quinolone-resistant in a man with persistent urethritis: the tip of the British iceberg?一名患有持续性尿道炎男性的大环内酯类和喹诺酮类耐药情况：这是英国的冰山一角吗？
Sex Transm Infect. 2017 Dec;93(8):556-557. doi: 10.1136/sextrans-2016-053077. Epub 2017 Apr 24.
7
Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.支原体属生殖支原体对大环内酯类和氟喹诺酮类药物耐药相关突变的流行率：系统评价和荟萃分析。
Lancet Infect Dis. 2020 Nov;20(11):1302-1314. doi: 10.1016/S1473-3099(20)30154-7. Epub 2020 Jul 2.
8
Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.由于大环内酯类和氟喹诺酮类耐药，莫西沙星治疗生殖支原体感染失败。
Int J STD AIDS. 2013 Oct;24(10):822-8. doi: 10.1177/0956462413502008. Epub 2013 Aug 29.
9
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium.生殖支原体对大环内酯类和氟喹诺酮类药物的耐药性不断增加。
Emerg Infect Dis. 2017 May;23(5):809-812. doi: 10.3201/eid2305.161745.
10
Doxycycline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitalium.强力霉素与司帕沙星联合治疗高度耐药的生殖支原体。
Emerg Infect Dis. 2020 Aug;26(8):1870-1874. doi: 10.3201/eid2608.191806.
引用本文的文献
1
Implementation of Diagnostics with Macrolide-Resistance Detection Improves Patient Treatment Outcomes in Bulgaria.实施具有大环内酯类耐药性检测功能的诊断方法可改善保加利亚患者的治疗效果。
Diagnostics (Basel). 2024 Nov 26;14(23):2665. doi: 10.3390/diagnostics14232665.
2
Detection of macrolide and fluoroquinolone resistance-associated 23S rRNA and parC mutations in Mycoplasma genitalium by nested real-time PCR.巢式实时 PCR 检测生殖支原体中与大环内酯类和氟喹诺酮类耐药相关的 23S rRNA 和 parC 突变。
Front Cell Infect Microbiol. 2023 Oct 20;13:1271392. doi: 10.3389/fcimb.2023.1271392. eCollection 2023.
3
Global analysis on the mutations associated with multidrug-resistant urogenital mycoplasmas and ureaplasmas infection: a systematic review and meta-analysis.全球分析与多药耐药泌尿生殖支原体和脲原体感染相关的突变：系统评价和荟萃分析。
Ann Clin Microbiol Antimicrob. 2023 Aug 10;22(1):70. doi: 10.1186/s12941-023-00627-6.
4
prevalence, antimicrobial resistance-associated mutations, and coinfections with non-viral sexually transmitted infections in high-risk populations in Guatemala, Malta, Morocco, Peru and South Africa, 2019-2021.2019 - 2021年危地马拉、马耳他、摩洛哥、秘鲁和南非高危人群中的患病率、抗菌药物耐药性相关突变以及与非病毒性传播感染的合并感染情况
Front Microbiol. 2023 Feb 22;14:1130762. doi: 10.3389/fmicb.2023.1130762. eCollection 2023.
5
Latest Advances in Laboratory Detection of Mycoplasma genitalium.生殖支原体的实验室检测最新进展
J Clin Microbiol. 2023 Mar 23;61(3):e0079021. doi: 10.1128/jcm.00790-21. Epub 2023 Jan 4.
6
Performance of the first commercial dual resistance assay, AmpliSens -ML/FQ-Resist-FL, for detection of potential macrolide and quinolone resistance-associated mutations and prevalence of resistance mutations in St. Petersburg, Russia.俄罗斯圣彼得堡地区首个商业化的双重耐药检测试剂盒（AmpliSens-ML/FQ-Resist-FL）的性能评估，用于检测潜在的大环内酯类和氟喹诺酮类耐药相关突变以及耐药突变的流行率。
Sex Transm Infect. 2023 May;99(3):191-194. doi: 10.1136/sextrans-2021-055249. Epub 2022 Jun 16.
7
Novel probe-based melting curve assays for the characterization of fluoroquinolone resistance in Mycoplasma genitalium.基于新型探针的熔解曲线分析方法鉴定解脲支原体对氟喹诺酮类药物的耐药性。
J Antimicrob Chemother. 2022 May 29;77(6):1592-1599. doi: 10.1093/jac/dkac097.
8
Recent advances in understanding and combatting .在理解和对抗方面的最新进展。 （原句不完整，此为按现有内容翻译）
Fac Rev. 2020 Oct 30;9:3. doi: 10.12703/b/9-3. eCollection 2020.
9
Detection of gene mutations associated with quinolone resistance in : evaluation of a multiplex real-time PCR assay.检测与喹诺酮类药物耐药相关的基因突变：多重实时 PCR 检测方法的评估。
J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001257. Epub 2021 Feb 19.
10
Nonquinolone Options for the Treatment of in the Era of Increased Resistance.在耐药性增加时代治疗[疾病名称未给出]的非喹诺酮类选择
Open Forum Infect Dis. 2020 Jul 13;7(8):ofaa291. doi: 10.1093/ofid/ofaa291. eCollection 2020 Aug.
本文引用的文献
1
Moxifloxacin and Sitafloxacin Treatment Failure in Mycoplasma genitalium Infection: Association with parC Mutation G248T (S83I) and Concurrent gyrA Mutations.莫西沙星和司帕沙星治疗失败支原体生殖器感染：与 parC 突变 G248T（S83I）和并发 gyrA 突变相关。
J Infect Dis. 2020 Mar 2;221(6):1017-1024. doi: 10.1093/infdis/jiz550.
2
Clearance of Mycoplasma genitalium Infection With Moxifloxacin in the Presence of Quinolone Resistance-Associated Mutations.存在喹诺酮类耐药相关突变时莫西沙星清除泌尿生殖道支原体感染。
Sex Transm Dis. 2020 Mar;47(3):197-198. doi: 10.1097/OLQ.0000000000001095.
3
Resistance-Guided Antimicrobial Therapy Using Doxycycline-Moxifloxacin and Doxycycline-2.5 g Azithromycin for the Treatment of Mycoplasma genitalium Infection: Efficacy and Tolerability.采用多西环素-莫西沙星和多西环素-2.5 g 阿奇霉素的耐药指导抗菌治疗用于治疗支原体生殖器感染：疗效和耐受性。
Clin Infect Dis. 2020 Sep 12;71(6):1461-1468. doi: 10.1093/cid/ciz1031.
4
British Association for Sexual Health and HIV national guideline for the management of infection with (2018).英国性健康与艾滋病协会关于[具体感染名称未给出]感染管理的国家指南（2018年）
Int J STD AIDS. 2019 Sep;30(10):938-950. doi: 10.1177/0956462419825948. Epub 2019 Jul 7.
5
Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.耐莫昔沙星和敏感的支原体生殖器菌株中 ParC 和 GyrA 的突变。
PLoS One. 2018 Jun 8;13(6):e0198355. doi: 10.1371/journal.pone.0198355. eCollection 2018.
6
Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation.支原体生殖器感染耐药指导序贯治疗的结局：一项前瞻性评估。
Clin Infect Dis. 2019 Feb 1;68(4):554-560. doi: 10.1093/cid/ciy477.
7
Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection.普那霉素治疗耐大环内酯类药物的生殖支原体感染。
Emerg Infect Dis. 2018 Feb;24(2):328-335. doi: 10.3201/eid2402.170902.
8
New Horizons in Mycoplasma genitalium Treatment.生殖支原体治疗的新视野
J Infect Dis. 2017 Jul 15;216(suppl_2):S412-S419. doi: 10.1093/infdis/jix132.
9
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium.生殖支原体对大环内酯类和氟喹诺酮类药物的耐药性不断增加。
Emerg Infect Dis. 2017 May;23(5):809-812. doi: 10.3201/eid2305.161745.
10
Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection.莫西沙星治疗生殖支原体感染疗效的荟萃分析。
Int J STD AIDS. 2017 Oct;28(11):1106-1114. doi: 10.1177/0956462416688562. Epub 2017 Jan 24.
Zotero 插件